Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

3

Predictors of Lamivudine Resistance in Patients with Chronic Hepatitis B Virus Infection

Jeong Heo , Mong Cho , Byung Mann Cho , Sun Mi Lee , Tae Oh Kim , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song

Clin Mol Hepatol. 2007;13(2):157-165. Published online January 1, 1970

View: 2734 Download: 15

Clinical Outcomes of Lamivudine Therapy in HBeAg Positive Chronic Hepatitis B with Minimally Elevated ALT

Dong Ha Han , Neung Hwa Park , Jung Woo Shin , Seok Won Jung , Young Tae Hwang , Hyun Soo Kim , In Du Jeong , Sung Jo Bang , Do Ha Kim

Clin Mol Hepatol. 2007;13(2):146-156. Published online January 1, 1970

View: 2729 Download: 20

Comparison of Clinical Outcome Between Patients Continuing and Discontinuing Lamivudine Therapy in Acute Exacerbation After Viral breakthrough During Lamivudine Therapy in Chronic Hepatitis B

Jong Ryul Eun

Clin Mol Hepatol. 2006;12(2):184-190. Published online January 1, 1970

View: 2103 Download: 14

Correlation of HBV DNA Level and Viral Breakthrough During Lamivudine Therapy for Chronic Hepatitis B

Hee Seung Park , Dong Hyun Lee , Jeong Heo , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song , Mong Cho

Clin Mol Hepatol. 2006;12(2):173-183. Published online January 1, 1970

View: 2728 Download: 22

Clinical Outcomes after Discontinuation of Lamivudine in Chronic Hepatitis B Patients with Lamivudine Resistant HBV Mutant

Jeong Ki Kim, M.D. Seong Gyu Hwang, M.D. Hyeuk Park, M.D. Hong Youp Choi, M.D. Hyo Jin Cho, B.S. Kwang Hyun Ko, M.D. Sung Pyo Hong, M.D. Pil Won Park, M.D. Nam Keun Kim, Ph.D. and Kyu Sung Rim, M.D.

Clin Mol Hepatol. 2005;11(3):227-242. Published online January 1, 1970

View: 2943 Download: 14

Efficacy and Safety of Adefovir Dipivoxil in Patients with Decompensated Liver Cirrhosis with Lamivudine Resistance Compared to Patients with Compensated Liver Disease

Won Moon, M.D., Moon Seok Choi, M.D., Yu Mi Moon, R.N., Seung Woon Paik, M.D., Joon Hyoek Lee, M.D., Kwang Cheol Koh, M.D., Byung Chul Yoo, M.D., Jong Chul Rhee, M.D. and Sang Goon Shim, M.D.

Clin Mol Hepatol. 2005;11(2):125-134. Published online January 1, 2000

View: 2258 Download: 16

HBV-specific CD8⁺ T cells for Sustained HBeAg Seroconversion after Lamivudine Therapy

Chun Kyon Lee, M.D., Kwang-Hyub Han, M.D. Jeong Hun Suh, M.D., Young Suk Cho, M.D., Sun Young Won, M.D., Chae Yoon Chon, M.D. Young Myoung Moon, M.D. and In Suh Park, M.D.

Clin Mol Hepatol. 2005;11(1):34-42. Published online January 1, 2000

View: 2150 Download: 13

2

Treatment of Chronic Hepatitis B ; The Efficacy of Lamivudine in Korean Patients with Chronic Hepatitis B

Jong Young Choi

Clin Mol Hepatol. 2005;11(1):25-30. Published online January 1, 2000

View: 2330 Download: 12

Treatment of Chronic Hepatitis B ; Antiviral Therapy in Hepatitis B Carriers Undergoing Immunosuppressive Treatment or Cytotoxic Chemotherapy

Jung Hwan Yoon

Clin Mol Hepatol. 2005;11(1):17-20. Published online January 1, 2000

View: 2292 Download: 12

Treatment of Chronic Hepatitis B ; Dose and Treatment Duration of Regimen

Young Oh Kweon

Clin Mol Hepatol. 2005;11(1):13-16. Published online January 1, 2000

View: 2409 Download: 13

Treatment of Chronic Hepatitis B ; Indication of Drug Therapy in Patients with Chronic Hepatitis B

Mong Cho

Clin Mol Hepatol. 2005;11(1):1-8. Published online January 1, 2000

View: 2698 Download: 17

3

The Clinical Meaning of the Emergence of Viral Breakthrough during Lamivudine Treatment in Patients with Hepatitis B Virus Related Chronic Liver Disease

Chan Bog Park , Hyun Jeung Lim , Byung Cheol Yun , Sang Uk Lee , Byung Hoon Han

Clin Mol Hepatol. 2004;10(2):108-116. Published online January 1, 1970

View: 2552 Download: 18

Pretreatment ALT Level and Histologic Activity as Predictors of HBeAg Loss in Lamivudine Treatment for Chronic Hepatitis B

Young Oh Kweon, M.D. and Kyung Hee Kang, M.D.

Clin Mol Hepatol. 2004;10(1):31-41. Published online January 1, 1970

View: 2551 Download: 14

Adequacy of Immediate Lamivudine Trial for Chronic Hepatitis B Patients with Acute Exacerbation

Chun Kyon Lee, M.D., Jeong Hun Suh, M.D., Yong Suk Cho, M.D., Sun Young Won, M.D. and In Suh Park, M.D.

Clin Mol Hepatol. 2004;10(1):22-30. Published online January 1, 1970

View: 2274 Download: 19

2

Therapeutic Strategy for YMDD Mutants of Hepatitis B Virus

Soo Hyung Ryu, M.D. and Young-Hwa Chung, M.D.

Clin Mol Hepatol. 2004;10(1):1-10. Published online January 1, 1970

View: 2543 Download: 17

3

Predictive Factors and Clinical Outcome of Viral Breakthrough during Lamivudine Treatment for Chronic Hepatitis B Infection

Park Neunghwa , Sin Jeongu , Park Jongho , Bang Seongjo , Kim Daehyeon , Ju Gwanglo , Kim Doha

Clin Mol Hepatol. 2003;9(4):293-303. Published online January 1, 1970

View: 2275 Download: 12

Efficacy of Lamivudine Re-treatment and Relapse Patterns after Initial Lamivudine Treatment for Chronic Hepatitis B Infection

Jong Ho Park, M.D., Neung Hwa Park, M.D., Jung Woo Shin, M.D., Sung-Jo Bang, M.D., Dae-Hyun Kim, M.D., Kwang Ro Joo, M.D. and Do Ha Kim, M.D.

Clin Mol Hepatol. 2003;9(3):188-197. Published online January 1, 1970

View: 2418 Download: 13

Efficacy of Lamivudine in Patients with Hepatitis B e Antigen-Negative Chronic Liver Diseases

In Du Jeong , Neung Hwa Park , Byung Chul Kim , Jee Hyun Park , Kwang Won Seo , Dae Hyun Kim , Kwang Ro Joo , Do Ha Kim

Clin Mol Hepatol. 2003;9(2):69-78. Published online January 1, 1970

View: 2716 Download: 11

Efficacy and Safety of Long-term Lamivudine Therapy in the Patients with Decompensated Liver Cirrhosis Secondary to Hepatitis B

Tae Wook Park, M.D., Young Min Park, M.D., Si Hyun Bae, M.D. Jeong Won Jang, M.D. Soon Woo Nam, M.D. Jong Young Choi, M.D. Seung Kew Yoon, M.D. Se Hyun Cho, M.D. Jin Mo Yang, M.D. Nam Ik Han, M.D. Byung Min Ahn, M.D. Young Suk Lee, M.D. Chang Don Lee, M.D. and Doo Ho Park, M.D.

Clin Mol Hepatol. 2002;8(4):428-435. Published online January 1, 1970

View: 2353 Download: 19

Therapeutic Efficacy of Lamivudine in Patients With Hepatitis B Virus-Related Decompensated Cirrhosis in Korea

Saera Jung, M.D., Dong Jin Suh, M.D., Hyun Ju Park, M.D., Young Hwan Park, M.D. Hee Gon Song, M.D., Han Chu Lee, M.D., Young-Hwa Chung, M.D. and Yung Sang Lee, M.D.

Clin Mol Hepatol. 2002;8(4):418-427. Published online January 1, 2000

View: 2712 Download: 17

Clinical and Virologic Characteristics of Lamivudine Resistance in HBV-associated Chronic Liver Disease

Sun Suk Kim, M.D., Moon Gi Chung, M.D., Ki Tak Ju, M.D., Dong Kyun Park, M.D. Oh Sang Kwon, M.D.,Yang Suh Koo, M.D., Yu Kyung Kim, M.D., Duck Ju Choi, M.D. Yu Jin Hwang, Ph.D.* and Ju Hyun Kim, M.D.

Clin Mol Hepatol. 2002;8(4):405-417. Published online January 1, 1970

View: 2228 Download: 15

Viral Breakthrough in HbeAg-Negative Chronic Hepatitis B Patients Receiving Lamivudine Therapy

Yun Jung Chang, M.D., Jeong Yoon Yim, M.D., Nam Young Cho, M.D., Chang Won Choi, M.D., Soo Jung Baek, M.D., Soo Hyun Ahn, M.D., Do Won Choi, M.D., Yong Dae Kwon, M.D., Sun Suk Kim, M.D.**, Oh Sang Kwon, M.D.**, Ju Hyun Kim, M.D.**, Jong Eun Yeon, M.D., Jin Won Song, M.D.*, Kwan Soo Byun, M.D. and Chang Hong Lee, M.D.

Clin Mol Hepatol. 2002;8(4):397-404. Published online January 1, 1970

View: 2526 Download: 18

Clinical Outcome in Cases of Viral Breakthrough During Lamivudine Therapy in Chronic Hepatitis B Patients

Soo Hyun Ahn, M.D., Yun Jung Chang, M.D., Seong Nam Oh, M.D., Do Won Choi, M.D., Soo Jung Baek, M.D., Won Seok Jeong, M.D., Chang Won Choi, M.D., Kyoung Oh Kim, M.D., Hyung Joon Yim, M.D., Nam Young Jo, M.D., Jong Jae Bak, M.D., Jae Seon Kim, M.D., Young-Tae Bak, M.D., Myung Seok Lee, M.D.*, Jong Eun Yeon M.D., Kwan Soo Byun, M.D. and Chang Hong Lee, M.D.

Clin Mol Hepatol. 2002;8(4):389-396. Published online January 1, 1970

View: 2291 Download: 17

Long - term Efficacy and Durability of Lamivudine Therapy in Patients with Chronic Hepatitis B

Chae Yoon Chon,Sang Hoon Ahn,Kwang Hyub Han,Young Myoung Moon,Sung Pil Hong,Yong Han Paik,Byung Soo Moon

Clin Mol Hepatol. 2001;7(4):423-431. Published online January 1, 1970

View: 2337 Download: 14

Efficacy of 1 - Year Lamivudine Treatment in the Patient of Chronic B Hepatitis and Liver Cirrhosis

Yong Song Kim,Seung Soo Kim,Hung Yong Jin,Myung Sin Ma,Seung Ok Lee,Soo Teik Lee,Dae Ghon Kim,Deuk Soo Ahn

Clin Mol Hepatol. 2001;7(2):171-180. Published online January 1, 2000

View: 2149 Download: 12

The Therapeutic Effects of Lamivudine and Detection of Mutations in YMDD Motif of Hepatitis B Virus Genome in Chronic Hepatitis B Patients

Mi Sung Kim, M.D., Hee Bok Chae, M.D., Ki Won Choi, M.D., Tae Won Lee, M.D., Seon Mee Park, M.D., Sei Jin Youn, M.D., Suk Chul Bae, Pharm. D.*

Clin Mol Hepatol. 2001;7(2):162-170. Published online January 1, 2000

View: 2880 Download: 13

The Effect of Lamivudine Therapy for Chronic Liver Disease due to Hepatitis B Virus Infection

Neung Hwa Park,Kwang Ro Joo,Do Ha Kim

Clin Mol Hepatol. 2001;7(1):77-89. Published online January 1, 2000

View: 2469 Download: 20

Lamivudine-Resistance in Patients with Chronic Hepatitis B and/or Cirrhosis and Detection of Mutations in YMDD Motif of Hepatitis B Virus Genome

Sung Ho Kang,Young Min Park,Jong Young Choi,Je Hyun Shin,Tae Wook Park,Si Hyun Bae,Byung Hun Byun,Byung Min Ahn,Chang Don Lee,Sang Bok Cha,Hee Sik Sun,Doo Ho Park,Boo Sung Kim

Clin Mol Hepatol. 2001;7(1):15-33. Published online January 1, 2000

View: 2433 Download: 16

1

Which Method Is Appropriate in Defining the Responsiveness to Lamivudine?

Han Chu Lee,Dong Jin Suh

Clin Mol Hepatol. 2001;7(1):1-5. Published online January 1, 2000

View: 2078 Download: 14

3

Efficacy of Lamivudine in Patients with HBeAg-Negative and HBV DNA-Positive Chronic Liver Disease

Hye Seung Yoo,Han Joo Lee,Young Hwa Jung,Young Sang Lee,Dong Jin Seo

Clin Mol Hepatol. 2000;6(4):488-494. Published online January 1, 2000

View: 2201 Download: 13

1 | 2 | 3 |

Viewed By 5596	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4811	MAFLD: How is it different from NAFLD?
Viewed By 4554	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3718	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3707	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search